18.85
Usana Health Sciences Inc 주식(USNA)의 최신 뉴스
USANA Celebrates 30 Years of Excellence in Canada - marketscreener.com
USANA Health Sciences Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics - Markets Mojo
Are investors undervaluing USANA Health Sciences (USNA) right now? - MSN
USANA Health Sciences (USNA) Projected to Post Earnings on Tuesday - MarketBeat
USANA Health Sciences Q3 2025 Earnings Preview - MSN
Q4 Rundown: USANA (NYSE:USNA) Vs Other Personal Care Stocks - Yahoo Finance
USANA (USNA) director reports RSU conversion and tax-withholding share disposition - Stock Titan
USANA (USNA) director acquires 1,057 shares via RSU exercise - Stock Titan
USANA (USNA) director converts 1,057 RSUs into common stock - Stock Titan
USANA (USNA) director receives 1,057 shares from RSU vesting - Stock Titan
USANA (USNA) director Peggie Pelosi exercises RSUs, with 668 shares for taxes - Stock Titan
[Form 4] USANA HEALTH SCIENCES INC Insider Trading Activity - Stock Titan
USANA (USNA) director Xia Ding converts RSUs and withholds 391 shares for taxes - Stock Titan
USANA debuts Glow, a skin capsule tied to trials in 162 women - Stock Titan
USANA Health Sciences (NYSE:USNA) Lowered to "Hold" Rating by Zacks Research - MarketBeat
USANA Malaysia Launches New Vitamin D Supplement with Record-Breaking Jogging Event, Earning Malaysia Book of Records Title – Company AnnouncementFT.com - Financial Times
Q3 EPS Estimates for USANA Health Sciences Cut by Sidoti - MarketBeat
Are Investors Undervaluing USANA Health Sciences (USNA) Right Now? - Yahoo Finance
What to Know About USANA (USNA) Stock Today (Momentum Building) 2026-04-15Collaborative Trading Signals - UBND thành phố Hải Phòng
USANA Health Sciences (NYSE:USNA) Raised to "Strong-Buy" at Zacks Research - MarketBeat
USANA Schedules First Quarter 2026 Earnings Release and Conference Call - ChartMill
USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates - Eastern Progress
Published on: 2026-04-14 00:02:07 - baoquankhu1.vn
Aug Spikes: Is USANA Health Sciences Inc stock influenced by commodity prices2026 EndofYear Setup & Stock Portfolio Risk Management - baoquankhu1.vn
[ARS] USANA HEALTH SCIENCES INC SEC Filing - Stock Titan
USANA (NYSE: USNA) details 2026 virtual meeting, board and pay votes - Stock Titan
USANA Health Sciences, Inc. (USNA) Stock forecasts - Yahoo Finance UK
USANA Health Sciences Announces Record Second Quarter Financial Results - Yahoo
Market Recap: What is the target price for USANA Health Sciences Inc stock2026 Momentum & Fast Gain Swing Trade Alerts - baoquankhu1.vn
USANA CEO Kevin Guest Calls for Daily Health Routines on World Health Day - Sahm
Published on: 2026-04-02 10:27:50 - baoquankhu1.vn
USANA Health (USNA) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Eastern Progress
Major USANA (USNA) holder Wentz updates 40.1% ownership via Gull Global - Stock Titan
Vanguard (USNA) amendment shows 0 shares; subsidiaries report separately - Stock Titan
Published on: 2026-03-27 12:44:15 - baoquankhu1.vn
Aug Spikes: Will USANA Health Sciences Inc outperform during market rallies2026 Price Swings & Detailed Earnings Play Strategies - baoquankhu1.vn
Tested, Trusted, Approved: USANA CellSentials Earns ConsumerLab.com Seal of Approval for Purity and Potency - Finviz
Fuller sells USANA [USNA] shares worth $17986 By Investing.com - Investing.com Australia
Insider Selling: USANA Health Sciences (NYSE:USNA) Director Sells 1,058 Shares of Stock - MarketBeat
Fuller sells USANA [USNA] shares worth $17986 - Investing.com
USANA (USNA) director Gilbert Fuller sells 1,058 shares, now holds none - Stock Titan
USANA Health Sciences Experiences Valuation Adjustment Amidst Competitive Market Dynamics - Markets Mojo
Loss Report: Will USANA Health Sciences Inc outperform during market ralliesQuarterly Growth Report & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
USANA Health Sciences 2025-2026 Business Overview: Core Nutritional, Direct-to-Consumer Segments, Product Lines, and Growth Strategy 40414243444546 - minichart.com.sg
USANA Health Sciences: $925.3M Revenue, $0.58 Diluted EPS in 10-K - TradingView
USANA (NYSE: USNA) outlines 2025 sales, China exposure and Hiya expansion - Stock Titan
USANA Health Sciences : Annual Report for Fiscal Year Ending January 3, 2025 (Form 10-K) - marketscreener.com
USANA Health Sciences Hits New 52-Week Low at $16.71 - Markets Mojo
EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y - Finviz
USANA outlines 4% sales growth target for 2026 amid omnichannel and product innovation push - MSN
Published on: 2026-03-07 21:51:28 - baoquankhu1.vn
자본화:
|
볼륨(24시간):